Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)

View source ↗

Summary

This clinical trial update notes the completion of an observational study evaluating Avastin (bevacizumab) in combination with interferon alpha-2a in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Interferon alfa-2a (interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Cell Cancer | Status: COMPLETED